Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 357

1.

A comparison of Wharton's jelly and cord blood as a source of mesenchymal stem cells for diabetes cell therapy.

El-Demerdash RF, Hammad LN, Kamal MM, El Mesallamy HO.

Regen Med. 2015;10(7):841-55. doi: 10.2217/rme.15.49. Epub 2015 Nov 6.

PMID:
26541176
2.

Undifferentiated Wharton's Jelly Mesenchymal Stem Cell Transplantation Induces Insulin-Producing Cell Differentiation and Suppression of T-Cell-Mediated Autoimmunity in Nonobese Diabetic Mice.

Tsai PJ, Wang HS, Lin GJ, Chou SC, Chu TH, Chuan WT, Lu YJ, Weng ZC, Su CH, Hsieh PS, Sytwu HK, Lin CH, Chen TH, Shyu JF.

Cell Transplant. 2015;24(8):1555-70. doi: 10.3727/096368914X683016. Epub 2014 Jul 15.

PMID:
25198179
3.

Intravenous vs intraperitoneal transplantation of umbilical cord mesenchymal stem cells from Wharton's jelly in the treatment of streptozotocin-induced diabetic rats.

El-Hossary N, Hassanein H, El-Ghareeb AW, Issa H.

Diabetes Res Clin Pract. 2016 Nov;121:102-111. doi: 10.1016/j.diabres.2016.09.008. Epub 2016 Sep 21.

PMID:
27693839
4.

Potency of umbilical cord blood- and Wharton's jelly-derived mesenchymal stem cells for scarless wound healing.

Doi H, Kitajima Y, Luo L, Yan C, Tateishi S, Ono Y, Urata Y, Goto S, Mori R, Masuzaki H, Shimokawa I, Hirano A, Li TS.

Sci Rep. 2016 Jan 5;6:18844. doi: 10.1038/srep18844.

5.

Isolation and characterization of Wharton's jelly-derived multipotent mesenchymal stromal cells obtained from bovine umbilical cord and maintained in a defined serum-free three-dimensional system.

Cardoso TC, Ferrari HF, Garcia AF, Novais JB, Silva-Frade C, Ferrarezi MC, Andrade AL, Gameiro R.

BMC Biotechnol. 2012 May 4;12:18. doi: 10.1186/1472-6750-12-18.

6.

Isolation and characterization of canine Wharton's jelly-derived mesenchymal stem cells.

Seo MS, Park SB, Kang KS.

Cell Transplant. 2012;21(7):1493-502.

PMID:
22732242
7.

Exendin-4 enhances the differentiation of Wharton's jelly mesenchymal stem cells into insulin-producing cells through activation of various β-cell markers.

Kassem DH, Kamal MM, El-Kholy Ael-L, El-Mesallamy HO.

Stem Cell Res Ther. 2016 Aug 11;7(1):108. doi: 10.1186/s13287-016-0374-4.

8.

Mesenchymal Stem Cells from Wharton's Jelly and Amniotic Fluid.

Joerger-Messerli MS, Marx C, Oppliger B, Mueller M, Surbek DV, Schoeberlein A.

Best Pract Res Clin Obstet Gynaecol. 2016 Feb;31:30-44. doi: 10.1016/j.bpobgyn.2015.07.006. Epub 2015 Sep 10. Review.

PMID:
26482184
9.

Priming Wharton's jelly-derived mesenchymal stromal/stem cells with ROCK inhibitor improves recovery in an intracerebral hemorrhage model.

Lee HS, Kim KS, Lim HS, Choi M, Kim HK, Ahn HY, Shin JC, Joe YA.

J Cell Biochem. 2015 Feb;116(2):310-9. doi: 10.1002/jcb.24969.

PMID:
25185536
10.

Human chorionic-plate-derived mesenchymal stem cells and Wharton's jelly-derived mesenchymal stem cells: a comparative analysis of their potential as placenta-derived stem cells.

Kim MJ, Shin KS, Jeon JH, Lee DR, Shim SH, Kim JK, Cha DH, Yoon TK, Kim GJ.

Cell Tissue Res. 2011 Oct;346(1):53-64. doi: 10.1007/s00441-011-1249-8. Epub 2011 Oct 11.

PMID:
21987220
11.

Wharton's jelly mesenchymal stromal/stem cells derived under chemically defined animal product-free low oxygen conditions are rich in MSCA-1(+) subpopulation.

Devito L, Badraiq H, Galleu A, Taheem DK, Codognotto S, Siow R, Khalaf Y, Briley A, Shennan A, Poston L, McGrath J, Gentleman E, Dazzi F, Ilic D.

Regen Med. 2014;9(6):723-32. doi: 10.2217/rme.14.60.

PMID:
25431909
12.

Treatment With Human Wharton's Jelly-Derived Mesenchymal Stem Cells Attenuates Sepsis-Induced Kidney Injury, Liver Injury, and Endothelial Dysfunction.

Cóndor JM, Rodrigues CE, Sousa Moreira Rd, Canale D, Volpini RA, Shimizu MH, Camara NO, Noronha Ide L, Andrade L.

Stem Cells Transl Med. 2016 Aug;5(8):1048-57. doi: 10.5966/sctm.2015-0138. Epub 2016 Jun 8.

13.

Altered expression of microRNAs in the neuronal differentiation of human Wharton's Jelly mesenchymal stem cells.

Zhuang H, Zhang R, Zhang S, Shu Q, Zhang D, Xu G.

Neurosci Lett. 2015 Jul 23;600:69-74. doi: 10.1016/j.neulet.2015.05.061. Epub 2015 Jun 3.

PMID:
26049006
14.

The effect of fibroblast growth factor on distinct differentiation potential of cord blood-derived unrestricted somatic stem cells and Wharton's jelly-derived mesenchymal stem/stromal cells.

Lee S, Park BJ, Kim JY, Jekarl D, Choi HY, Lee SY, Kim M, Kim Y, Park MS.

Cytotherapy. 2015 Dec;17(12):1723-31. doi: 10.1016/j.jcyt.2015.09.007.

PMID:
26589753
15.

Differentiation of human umbilical cord Wharton's jelly-derived mesenchymal stem cells into endometrial cells.

Shi Q, Gao J, Jiang Y, Sun B, Lu W, Su M, Xu Y, Yang X, Zhang Y.

Stem Cell Res Ther. 2017 Nov 2;8(1):246. doi: 10.1186/s13287-017-0700-5.

16.

DMSO- and Serum-Free Cryopreservation of Wharton's Jelly Tissue Isolated From Human Umbilical Cord.

Shivakumar SB, Bharti D, Subbarao RB, Jang SJ, Park JS, Ullah I, Park JK, Byun JH, Park BW, Rho GJ.

J Cell Biochem. 2016 Oct;117(10):2397-412. doi: 10.1002/jcb.25563. Epub 2016 Jun 23.

17.

Wharton's Jelly Mesenchymal Stromal Cells as a Feeder Layer for the Ex Vivo Expansion of Hematopoietic Stem and Progenitor Cells: a Review.

Lo Iacono M, Anzalone R, La Rocca G, Baiamonte E, Maggio A, Acuto S.

Stem Cell Rev. 2017 Feb;13(1):35-49. doi: 10.1007/s12015-016-9702-4. Review.

PMID:
27853939
18.

Freezing of Fresh Wharton's Jelly From Human Umbilical Cords Yields High Post-Thaw Mesenchymal Stem Cell Numbers for Cell-Based Therapies.

Fong CY, Subramanian A, Biswas A, Bongso A.

J Cell Biochem. 2016 Apr;117(4):815-27. doi: 10.1002/jcb.25375. Epub 2015 Sep 17.

PMID:
26365815
19.

Wharton's jelly or bone marrow mesenchymal stromal cells improve cardiac function following myocardial infarction for more than 32 weeks in a rat model: a preliminary report.

López Y, Lutjemeier B, Seshareddy K, Trevino EM, Hageman KS, Musch TI, Borgarelli M, Weiss ML.

Curr Stem Cell Res Ther. 2013 Jan;8(1):46-59.

20.

Effect of combined therapy of human Wharton's jelly-derived mesenchymal stem cells from umbilical cord with sitagliptin in type 2 diabetic rats.

Hu J, Wang F, Sun R, Wang Z, Yu X, Wang L, Gao H, Zhao W, Yan S, Wang Y.

Endocrine. 2014 Mar;45(2):279-87. doi: 10.1007/s12020-013-9984-0. Epub 2013 May 18.

PMID:
23686639

Supplemental Content

Support Center